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ABSTRACT
Objective: To investigate the release of bone morphogenetic protein-2 (BMP-2) and collagen type I proteins (COL1) from different sources of 
demineralized dentine matrix (DDM) and their chemotaxis to mouse osteoprogenitor cells.
Methods: The release kinetic of BMP-2 and COL1 was measured from custom-made DDM (CMDDM) and commercially available DDM (CADDM). 
Using Urist physicochemical method, CMDDM was collected from the extracted teeth in a certified dental clinic. Levels of BMP-2 and COL1 released 
were measured at days 1, 2, 3, 5, 7, 9, 11, and 13. Next, mouse osteoprogenitor cells, MC3T3-E1, were cultured with a variety of materials as follows: 
CMDDM, CADDM, Bio-Oss®, and blank control in transwell system. The number of cell migration was determined by crystal violet staining to explore 
chemotaxis of different DDMs to mouse osteoprogenitor cells.
Results: BMP-2 was detected at 588.32 ± 14.53 pg/ml from 5 g of CMDDM. In the release kinetic assay, the concentration of BMP-2 in the CMDDM 
group increased rapidly and peaked at 113.9 pg/ml on day 5, almost four times higher than that of CADDM. The release of COL1 showed similar 
pattern in both CMDDM and CADDM; however, the amount was significantly higher in the CMDDM group. In cell culture experiment, the number of 
migrated MC3T3-E1 was ranked as the highest in CMDDM, followed by CADDM and Bio-Oss® (p<0.05).
Conclusion: CMDDM released BMP-2 and COL1 greater than CADDM, which can induce more osteoblast-like cell migration. These results demonstrated 
a release kinetic of proteins and osteoinductivity of CMDDM, which supports a benefit of using autogenous bone graft.
Keywords: Demineralized dentine matrix, Chemotaxis, Cell migration, Osteoinduction, bone grafting.
INTRODUCTION
Every year, an estimated 2 million individuals worldwide suffer 
from bone defects due to trauma, infection, tumor, or congenital 
hereditary diseases caused by bony abnormalities. Bone grafts have 
been predominantly used to treat bony defects. Meanwhile, dental 
implant technologies are developing rapidly. A number of bone 
grafting applications have been widely used in clinic; as a result, 
numerous experiments of bone grafting and bone regeneration are held 
worldwide [1-3].
Demineralized dentine matrix (DDM) is a kind of dentin which was 
demineralized and obtained from extracted teeth as a kind of bone graft 
material [4-6]. The structure and composition of dentin is similar to 
that of bone, consisting of collagen type I (COL 1) 20%, hydroxyapatite 
(HA) 70%, and body fluid 10% by weight [7,8]. Dentin is thought to 
have a high osteoconductivity since it is a natural mineralized tissue 
consisting of HA. Furthermore, dentin matrix is expected to exhibit 
osteoinductivity because it contains bone morphogenetic proteins 
(BMPs) [8]. BMPs are multifunctional growth factors that belong to 
the transforming growth factor-β superfamily [9,10]. BMPs induced 
mesenchymal stem cells to migrate to a bone-forming site as well as 
induce their differentiation into an osteoblast to form bone [11,12].
In addition, DDM induces bone and cartilage formation independently by 
showing an ability to induce new bone formation in challenging location, 
suggesting a strong evidence of its osteoinduction [13]. However, the 
local pharmacokinetics are very important for the therapeutic efficacy 
of BMPs; for example, when BMP-2 is placed at the site of a bone defect, 
it is quickly dispersed from that site, resulting in minimal effect on bone 
formation and healing [11]. Therefore, it is necessary to explore an 
efficient material or delivery system that can slowly release BMPs with 
steady concentration [14,15]. Despite the wide use of DDM in bone defect 
treatment, the kinetic release of BMPs into the ambient environment has 
never been investigated before. In our study, we aimed to investigate the 
amount of BMP-2 and COL1 released from various sources of DDM and 
to investigate their chemotaxis capacity for osteoblast-like cell in an 
in vitro study using MC3T3-E1 cells.
METHODS
Study design
The production of custom-made DDM (CMDDM) was followed and 
modified from the method of Yagihashi et al. [6] and Yeomans and 
Urist [16]. Scanning electron microscopy (SEM) was used to visualize 
the physical characteristics and surface of CMDDM particles. Amount 
of BMP-2 protein was detected from 5 g each of commercially available 
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DDM (CADDM) and CMDDM, and then the release kinetic of BMP-2 
and COL1 proteins was measured from both groups at days 1, 2, 3, 5, 
7, 9, 11, and 13. Then, we cultured mouse osteoprogenitor cells with 
the presence of different DDMs and Bio-Oss® bone graft in transwell 
system, to investigate the chemotaxis of different materials to mouse 
osteoprogenitor cells. The release of BMP-2 and COL1 in their mediums 
was also detected.
Preparation of demineralized dentine matrix
In this experiment, two kinds of DDM were used, CADDM and CMDDM. 
CADDM was purchased by luminosity Chuang Bo Biomaterial 
Company in ShenZhen, China, whereas CMDDM was prepared using 
undecayed molar or premolar from anonymous patients who came 
for extraction in the Oral and Maxillofacial Surgery Department, the 
Affiliated Stomatology Hospital of Kunming Medical University. The 
principles of Helsinki declaration were followed as the protocol of 
the study, which was approved by the Ethical Committee of Kunming 
Medical University.
CMDDM was produced from modified method [6,16]. Briefly, 
the extracted tooth was washed with cold phosphate-buffered 
saline (PBS), and the enamel was entirely removed. Then, dentin, 
cementum, and pulp tissue were crushed into small particles, put 
into 4°C ethyl alcohol/diethyl ether for 4 h, and washed twice with 
deionized water. 0.6 mol/L HCl was used for demineralization for 
48 h at 4°C, incubated in 0.01 mol/L PBS which contains 10 mM/L 
iodoacetic acid in 37°C for 72 h, and repeatedly washed using an 
ultrasonic vibrator. The CMDDM was lyophilized and packaged. 
Afterward, it was sterilized by 25 kGy cobalt-60 radiation for 12 h 
and stored under −20°C.
The extraction of BMP-2 was detected by a modified method of Urist 
et al. [17] and Liu et al. [18]. Briefly, 5 g of CMDDM was put into 2M CaCl2 
for 24 h under 4°C, and then washed by deionized water. It was immersed 
in 0.5M ethylenediaminetetraacetic acid for 4 h and added with 8M LiCl 
for 24 h. After rinsing, CMDDM was put into 6 M urea, 0.5 M CaCl2, 1 mM 
phenylmethylsulfonyl fluoride, and 10 mM N-ethylmaleimide extracting 
solutions. After 24 h, the liquid supernatant was collected and dialyzed 
for 24 h in 0.25 M urea. The dialysate was collected and centrifuged at 
the speed of 12,000 rpm for 45 min, and the sediment was collected 
and dissolved in 6 M urea (−0.5 M CaCl2). The precipitate was dissolved 
and centrifuged for another 45 min. The final supernatant (190 µl) was 
collected for detection. Ten samples of CMDDM were extracted and 
measured in triplicate (n=10).
Detection of released bone morphogenetic protein-2 and collagen-I
100 mg of each CMDDM and CADDM was added into tubes containing 
1-ml serum-free DMEM medium (Hyclone, USA), mixed, labeled, and 
left in 37°C incubator for 1, 2, 3, 5, 7, 9, 11, and 13 days. Then, 900-μl 
medium from each tube was removed to centrifuge and kept under 
−80°C. Simple serum-free DMEM medium was used as a blank control. 
Enzyme-linked immunosorbent assay (ELISA) was used to test the level 
of BMP-2 (Abcam company, UK) and COL1 (CUSABIO company, USA) 
according to their manufacturing protocols. In transwell migration 
experiment, we also detected the release of BMP-2 and COL1 in their 
mediums after cultured with different DDMs at days 1–3, using the 
same protocol of ELISA.
Transwell cell migration assay
MC3T3-E1 is an osteoblast precursor cell line derived from Mus 
musculus (mouse) calvaria [19,20], which was bought from Kunming 
Institute of Zoology. Cell migration assays were evaluated using a 
two-chamber Transwell system (Transwell Costar, Corning, Acton, 
MA, USA). Briefly, 1 × 105/ml MC3T3-E1s were resuspended in 100-μl 
serum-free DMEM and seeded into the top chamber of the Transwell 
system, and 600 μl of serum-free DMEM with 100 mg DDMs or Bio-Oss® 
(Geistlich, Switzerland) or none (blank control) was added to the lower 
chambers (Fig. 1). After 24 h, 48 h, and 72 h incubation at 37°C in 5% 
CO2, MC3T3-E1 was fixed for 10 min with 95% ethyl alcohol and stained 
with 0.1% crystal violet for 20 min. For quantification of the migrated 
cells, five random microscopic fields/filter at ×100 were selected for 
cell counting. Measurements were done in triplicate: five independent 
experiments (n=5) and results were presented as mean and standard 
deviation (SD) in each experiment.
Statistical analysis
All data were expressed as the mean ± SD. Statistical analysis for the 
above assays was performed using ANOVA for repeated measurement 
analysis of variance and Tukey’s HSD test for individual comparison. 
Statistical Package for the Social Sciences statistical software 
(version 13.0; SPSS Inc., Chicago, IL, USA) was used in this experiment. 
The level for statistical significance was set at p<0.05.
RESULTS
Characteristics of custom-made demineralized dentine matrixs 
and its amount of bone morphogenetic protein-2
Visual photograph revealed the characteristic of light-yellow dried 
powder (Fig. 2a). The SEM photographs demonstrated a particle size 
of 0.4–1.0-mm CMDDM which has relatively smooth surface. Many 
micro-and macro-fractures were observed in the majority of particles 
(Fig. 2b). The average amount of BMP-2 that can be extracted from 5 g 
of CMDDM was 588.32 ± 14.53 pg/ml, according to its calibration curve 
(Supplement Fig. 1 and Table 1). In other words, 1 g of our CMDDM can 
produce 117.67 ± 29.06 pg/ml.
The release kinetic of bone morphogenetic protein-2 and collagen 
type I
The release of BMP-2 and COL1 between CMDDM and CADDM was 
compared and the results are shown in Fig. 3a and b, respectively. 
We measured the released amount of BMP-2 and COL1 according to 
their calibrating curve of BMP-2 and COL1 (Supplement Figs. 1 and 2). 
The release of BMP-2 from both DDMs increased rapidly and peaked 
on day 5 with similar pattern. The released BMP-2 from CMDDM was 
significantly higher than that from CADDM at all time points (Fig. 3a 
and Supplement Table 1). In addition, the highest concentration of BMP-
2 from CMDDM was 113.90±6.06 pg/ml, whereas that of CADDM was 
36.47 ± 2.93. For COL1, the release of COL1 from both DDMs increased 
rapidly and peaked on day 9 with similar pattern. The released COL1 
from CMDDM was significantly higher than that from CADDM at days 2, 
5, and 9 (Fig. 3b and Supplement Table 2).
Fig. 1: Transwell-mediated MC3T3-E1 cell migration design
Fig. 2: Physical characteristics of custom-made demineralized 
dentine matrix (a), Scanning electron microscopy images of 
commercially available demineralized dentine matrix (b) (×70)
a b
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Migration assay
Next, we investigated the osteoinduction property of DDMs by culturing 
with MC3T3-E1 osteoblast-like cells. The migrated cells were stained by 
crystal violet as they appealed at the lower chamber membrane (Fig. 4a). 
In both CMDDM and CADDM groups, the number of MC3T3-E1 cells that 
migrated through the membrane was greater than those in Bio-Oss® 
and blank control (Fig. 4). In quantitative analysis, the average number 
of migrated MC3T3-E1 cells in CMDDM was significantly higher than 
that of the CADDM from day 1 to day 3 (p<0.05) (Fig. 4b).
During the culture of MC3T3-E1 cells with CMDDM, CADDM, and Bio-
Oss®, the release of BMP-2 and COL1 in the culturing medium was also 
measured. The BMP-2 and COL1 concentrations were steadily increased 
from day 1 to day 3 (Fig. 5a, b and Supplementary Tables 3, 4). The 
amount of BMP-2 from CMDDM was significantly higher than that from 
CADDM on day 2 and day 3 (p<0.05) (Fig. 5a). On day 3, the highest 
amount of BMP-2 from CMDDM group was 30.66 ± 3.77 pg/ml, whereas 
that of CADDM was 18.66 ± 0.87 (p<0.05) (Supplement Table 3). The 
amounts of COL1 released from CMDDM group were significantly 
higher than those from CADDM as early as day 1 and remain higher 
until day 3. Levels of COL1 are shown in Supplement Table 4. It was 
noted that the levels of BMP-2 and COL1 released from Bio-Oss® were 
at similar level with a blank control at all time points.
DISCUSSION
Natural bones are a complex assembly of parallel type I collagen 
nanofibrils and HA crystals precipitated on their surface [21]. 
COL1 has potential as a biomaterial for bone tissue engineering 
due to its abundance, biocompatibility, high porosity, facility for 
combination with other materials, easy processing, hydrophilicity, 
low antigenicity, absorbability in the body, etc. [10]. In addition, 
among the osteoinductive agents, growth factors are the most 
important molecules of the healing promotive factors, especially the 
BMPs [22-24]. DDMs exhibit osteoinductivity because it was reported 
to be containing BMPs [5,8]. Autogenous DDMs are also widely used 
in treatment in the extraction sockets of mandibular third molars, 
which showed superior healing of the dental sockets with autogenous 
DDM [4,5]. Many studies applied both mineralized dentin and DDM 
particles in dental implant surgery and obtained successful bone 
regeneration results [13, 25]. Moreover, recent study detected 
the different degree of mineralized dentin matrix after implant 
various kinds of DDM in animal. The partially demineralized dentin 
matrix (PDDM) resulted in higher degree of mineralization when 
compared with the undemineralized dentin matrix (UDDM) or the 
completely demineralized dentin (CDDM) [26]. In different methods 
of DDM preparation, Minamizato et al. described successful clinical 
applications of autogenous partially demineralized dentin matrix in 
socket preservation, sinus floor augmentation, and alveolar ridge 
augmentation [5]. Therefore, it is well acknowledged that application 
of DDM is useful and advantageous for bone grafting. The size of DDM 
was also reported to affect bone regeneration.
Nam et al. [27] investigated the effect of different sizes of DDM particles 
on bone healing in rabbit skull after 2, 4, and 8 weeks of implantations. 
The histomorphometric results revealed that DDM particles in 0.25–
1.0 mm size activated the majority of new bone formation. From our 
preparation, we successfully obtained the CMDDM particle size at 
0.4–1.0 mm which corresponds with the previous report. Furthermore, 
many studies have reported that bone graft materials with different 
particle sizes exhibit different bone-healing abilities [28,29]. Although 
still controversial, their results suggested that, the smaller the particle 
Fig. 3: The released bone morphogenetic protein-2 (a) Collagen type I (b) concentration from various sources of demineralized dentine 
matrix at different time points, *compared with commercially available demineralized dentine matrix (p<0.05)
a b
Fig. 4: The representative picture of MC3T3-E1 migration (a) at magnification ×100 and the number of cell migration (No./view), (b) when 
cultured with different materials from days 1–3, *compared with commercially available demineralized dentine matrix (p<0.05)
a b
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size of the material, the greater the formation of bone by increasing 
the surface area and more growth factors are secreted to facilitate 
the formation of new blood vessels. Therefore, it can be suggested 
that DDMs at a particular size can accelerate the differentiation of 
mesenchymal cells into osteoblasts, thus assisting the process of bone 
formation.
BMPs exert significant inductive effects on different stages of bone 
healing process such as the inflammatory reaction, angiogenesis, the 
soft and hard callus formation, and bone remodeling, but drawbacks 
include its rapid degradation and high costs [30,31]. The recombinant 
BMP-2 is predominantly used in culturing osteoprogenitor cells 
in order to induce osteoblast differentiation via SMADs signaling 
pathway. The concentrations vary from 50 to 100 ng/ml [32,33]. In 
the present study, extracted BMP-2 concentration from fresh dental 
tissues was detected lesser than those of previous reports, which may 
be explained by different sources of protein and different chemical 
treatments. Nevertheless, our results demonstrated that BMP-2 
from CMDDM can be slowly released and its concentration can be 
maintained up to 13 days, emphasizing a great potential of DDMs as 
a protein carrier material. In addition, the CMDDM released BMP-2 
from day 1 to day 13 in relatively high concentration, while the level 
of BMP-2 from CADDM dropped to baseline at day 13, suggesting 
that the characteristics of CMDDM are more beneficial than that of 
CADDM for grafting treatment in the early stage of bone healing. COL1 
concentration from both groups were released in the similar pattern 
and remained high concentration through day 13. It is likely that our 
extraction method could preserve protein structure and biological 
activity of BMP-2 protein than other methods that processed by 
different acid at different duration of decalcification [5,6,26,34]. 
In addition, the 25 kGy cobalt 60 of radiation was used in this 
study to ultimately sterilize the CMDDM, whereas CADDM was heat 
sterilized. The study of Antebi et al. [35] showed that, after bone 
grafting materials were exposed to 10–50 kGy, their osteoinduction 
did not alter, but when the radiation amount exceeded 50 kGy, 
the osteoinduction decreased. Thus, it can be explained that the 
composition and structure of proteins in CMDDM were lesser affected 
by irradiation in our study.
Cell migration is a manifestation of cell chemotaxis, which makes 
the cells autonomously move toward or deviate from the stimulation 
source when stimulated by the signal molecules. A large number of 
studies have shown that the migration of osteoblast is the key factor to 
bone fracture healing, and the osteoblast migration is directly related 
to the formation of new callus [36]. In our study, the MC3T3-E1 
cell derived from skull in the mouse was used to differentiate into 
osteoblasts by osteogenic induction. This experimental design is 
widely used in bone regeneration experiments [37,38]. The culture 
with DDMs indicated that DDM is nontoxic to cells and revealed a 
good biocompatibility which promoted MC3T3-E1 cell migration. 
Different types of commercial bone grafts demonstrated significantly 
higher proliferative activity and alkaline phosphatase activity in the 
late stage of bone marrow stem cell culture [3]. It may be due to 
time required for growth factors to be secreted from the materials, 
which was the probable cause of the initial lag phase observed in the 
experimental groups. In our study, CMDDM showed the strongest 
chemotaxis via the migration of preosteoblast at early day, when 
compared to CADDM and Bio-Oss®. This may be corresponding to 
the highest amount of released BMP-2 and COL1 from CMDDM that 
may implicate the result of molecular (BMP-2 and COL1) interaction 
with the cells. Noted, the levels of BMP-2 and COL1 released from a 
commonly used bone substitute, Bio-Oss®, was shown as similar level 
with a blank control.
Although most people have experienced tooth extraction, the amount of 
DDM obtained from clinical site is limited; meanwhile, the commercial 
DDMs are costly. Under the limitations, further studies should be 
continued investigating other types of materials which can effectively 
contain BMPs or other essential growth factors to prolong the protein’s 
release such that it would be a better osteoinductive material for bone 
regeneration engineering.
CONCLUSION
CMDDM was successfully prepared from modified protocol and was 
proved to be able to release BMP-2 and COL1 greater than the CADDM. 
Therefore, it is plausible that higher level of BMP-2 from the CMDDM 
could induce more osteoblast-like cell migration which has been 
suggested for good osteoinductivity. The results of this experiment 
showed an agreement with other studies that DDMs are competitive 
with an excellent grafting material.
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Fig. 5: The bone morphogenetic protein-2 (a) and collagen type I (b) concentrations were measured from culturing medium in different 
demineralized dentine matrix groups from days 1 to 3, *compared with commercially available demineralized dentine matrix (p<0.05)
a b
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SUPPLEMENT TABLES
Supplement Table 1: The released bone morphogenetic protein-2 concentration from various sources of demineralized dentine matrix 
at different time points (pg/ml), n=5, x±s
Groups 1 day 2 days 3 days 5 days 7 days 9 days 11 days 13 days
CMDDM 15.56±1.06 19.44±2.21 68.22±7.91 113.90±6.06 96.09±6.03 69.77±1.06 62.41±2.87 58.00±1.78
CADDM 1.24±0.87 10.15±1.62 14.40±2.37 36.47±2.93 20.99±2.21 19.44±1.73 7.82±1.73 6.42±1.25
Blank control 0.85±2.37 1.24±1.62 1.08±3.62 0.85±1.94 0.47±2.52 0.85±1.94 0.47±1.62 1.24±0.86
DDM: Demineralized dentine matrix, CADDM: Commercially available DDM, CMDDM: Custom-made DDM group
Supplement Table 2: The released collagen type I concentration from various sources of demineralized dentine matrix at different time 
points (ng/ml), n=5, x±s
Groups 1 day 2 days 3 days 5 days 7 days 9 days 11 days 13 days
CMDDM 0.10±0.09 0.43±0.08 0.36±0.08 1.26±0.14 0.09±0.08 4.42±0.08 2.88±0.12 2.93±0.16
CADDM 0.01±0.01 0.01±0.01 0.10±0.15 0.40±0.09 0.01±0.01 2.84±0.19 2.95±0.09 2.90±0.09
Blank control 0.01±0.07 0.01±0.01 0.01±0.01 0.01±0.01 0.01±0.01 0.01±0.01 0.01±0.01 0.01±0.01
DDM: Demineralized dentine matrix, CADDM: Commercially available DDM, CMDDM: Custom-made DDM group
Supplement Table 3: Bone morphogenetic protein-2 concentrations (pg/ml) after the different demineralized dentine matrix and 
Bio-Oss® bone graft cultured with MC3T3-E1 cells, (n=5), x̅±s
Groups 1 day 2 days 3 days
CMDDM 10.92±2.12 20.21±1.94 30.66±3.77
CADDM 10.92±0.87 12.08±1.62 18.66±0.87
Bio-Oss® 3.95±1.73 7.05±2.52 7.82±1.06
Control 4.72±1.37 6.66±2.74 7.82±1.06
DDM: Demineralized dentine matrix, CADDM: Commercially available DDM, CMDDM: Custom-made DDM group
Supplement Table 4: Collagen type I concentrations (ng/ml) in different demineralized dentin matrices and Bio-Oss® bone graft 
cultured with MC3T3-E1 cells, (n=5), x̅±s
Groups 1 day 2 days 3 days
CMDDM 0.75±0.06 3.12±0.07 5.34±0.07
CADDM 0.28±0.07 1.82±0.14 3.86±0.07
Bio-Oss® 0.12±0.01 0.11±0.01 0.13±0.02
Control 0.12±0.02 0.08±0.07 0.16±0.07
DDM: Demineralized dentine matrix, CADDM: Commercially available DDM, CMDDM: Custom-made DDM group
Supplement Fig. 1: Bone morphogenetic protein-2 calibration curve
SUPPLEMENT FIGURES
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